Figures & data
Figure 1. The flowchart for four regimens of RR/MDR-TB treatment.
Table 1. Characteristics of patients eligible for a rifampicin resistance/multidrug resistance tuberculosis.
Figure 2. The proportion of patients with favorable outcome rates of four regimens.
Figure 3. Cumulative sputum culture conversion rates of four treatment regimens in different months.
Figure 4. Incidence of adverse reactions of four regimens.
Table 2. Cost estimates of economic burden of four regimens.
Table 3. The results of cost-effectiveness analysis of four regimens.
Table A1. Characteristics of patients eligible for a programme of treating drug-resistant pulmonary tuberculosis.
Table A2. The diagnosis and treatment information of patients with drug-resistant pulmonary tuberculosis.
Data availability statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.